Chemoinformaics analysis of 13-Epoxy-Labd-14-En-11-One
| Molecular Weight | 320.473 | nRot | 1 |
| Heavy Atom Molecular Weight | 288.217 | nRig | 18 |
| Exact Molecular Weight | 320.235 | nRing | 3 |
| Solubility: LogS | -4.797 | nHRing | 1 |
| Solubility: LogP | 4.294 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 57.1434 |
| nHD | 1 | BPOL | 34.7066 |
| QED | 0.742 |
| Synth | 4.688 |
| Natural Product Likeliness | 2.656 |
| NR-PPAR-gamma | 0.055 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.819 |
| Pgp-sub | 0 |
| HIA | 0.031 |
| CACO-2 | -4.784 |
| MDCK | 0.000018 |
| BBB | 0.994 |
| PPB | 0.885511 |
| VDSS | 1.225 |
| FU | 0.11653 |
| CYP1A2-inh | 0.036 |
| CYP1A2-sub | 0.931 |
| CYP2c19-inh | 0.394 |
| CYP2c19-sub | 0.949 |
| CYP2c9-inh | 0.489 |
| CYP2c9-sub | 0.089 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.41 |
| CYP3a4-inh | 0.92 |
| CYP3a4-sub | 0.913 |
| CL | 7.541 |
| T12 | 0.14 |
| hERG | 0.014 |
| Ames | 0.059 |
| ROA | 0.083 |
| SkinSen | 0.201 |
| Carcinogencity | 0.236 |
| EI | 0.237 |
| Respiratory | 0.957 |
| NR-Aromatase | 0.918 |
| Antiviral | No |
| Prediction | 0.658612 |